OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029
MIAMI, Jan. 04, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK) (the “Company”) today announced the pricing of its private offering of $200.0 million aggregate principal amount of its Convertible Senior Notes due 2029 (the “Notes”). The Company granted the initial purchaser in the offering an option to purchase, within the 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $30.0 million aggregate principal amount of the Notes. The sale of the Notes is expected to close on January 9, 2024, subject to customary closing conditions.
Related news for (OPK)
- OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
- OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
- OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
- OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
- OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results